Mankind Pharma announced that the Annual General Meeting (AGM) of the company will be held on 9 August 2024.Powered by Capital Market - Live News

Mankind Pharma will hold a meeting of the Board of Directors of the Company on 31 July 2024.Powered by Capital Market - Live News

Net profit of Mankind Pharma rose 65.09% to Rs 471.24 crore in the quarter ended March 2024 as against Rs 285.44 crore during the previous quarter ended March 2023. Sales rose 18.92% to Rs 2441.10 crore in the quarter ended March 2024 as against Rs 2052.67 crore during the previous quarter ended March 2023.For the full year,net profit rose 49.23% to Rs 1912.90 crore in the year ended March 2024 as against Rs 1281.86 crore during the previous year ended March 2023. Sales rose 18.12% to Rs 10334.77 crore in the year ended March 2024 as against Rs 8749.43 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales2441.102052.67 19 10334.778749.43 18 OPM %24.2120.30 -24.5321.72 - PBDT676.26461.81 46 2797.611997.16 40 PBT571.58377.29 51 2399.361671.24 44 NP471.24285.44 65 1912.901281.86 49 Powered by Capital Market - Live News

Mankind Pharma has allotted 46,698 equity shares under ESOP on 10 May 2024. With this allotment, the paid up equity share capital has increased to 40,06,35,138 equity shares having face value of Re. 1/- each. Powered by Capital Market - Live News

Mankind Pharma will hold a meeting of the Board of Directors of the Company on 15 May 2024Powered by Capital Market - Live News